Welcome to our dedicated page for CONVERGE TECH SLTN news (Ticker: $CTSDF), a resource for investors and traders seeking the latest updates and insights on CONVERGE TECH SLTN stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CONVERGE TECH SLTN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CONVERGE TECH SLTN's position in the market.
Converge Technology Solutions Corp. reported its First Quarter 2024 Results, highlighting a third consecutive billion-dollar gross sales quarter. Key financial figures include gross sales of $1.01 billion, representing a 4.2% increase, a revenue decrease to $628.8 million, and a net loss of $3.5 million. The company's adjusted EBITDA increased to $42.2 million, and cash from operating activities rose to $110.9 million. Converge reduced its net debt significantly year-over-year. The Board declared a quarterly dividend of $0.015 per common share. Financial outlook for Q2 2024 includes expected gross profit of $175 million - $182 million and adjusted EBITDA of $43 million - $46 million. Conference call details for further information.
